Muscle pathology in the neuroleptic malignant syndrome
- 1 January 1987
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Neurologie
- Vol. 235 (2) , 120-121
- https://doi.org/10.1007/bf00718024
Abstract
In a fatal case of neuroleptic malignant syndrome, a muscle sample taken within 1h of death showed acute myopathic features with absence of muscle glycogen and neutral lipid. These features suggest that hyperpyrexia in this syndrome may be caused by heat production from uncoupled phosphorylation in muscle and imply that the primary biochemical abnormality responsible for this uncontrolled heat production might be muscular rather than hypothalamic.Keywords
This publication has 14 references indexed in Scilit:
- Recurrent neuroleptic malignant syndrome and hyponatraemia.Journal of Neurology, Neurosurgery & Psychiatry, 1986
- Neuroleptic Malignant SyndromeNew England Journal of Medicine, 1985
- Fatal hyperpyrexia after withdrawal of levodopaNeurology, 1984
- Neuroleptic malignant syndrome: Successful treatment with dantrolene and bromocriptineAnnals of Neurology, 1983
- Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.1983
- NEUROLEPTIC MALIGNANT SYNDROME AND MALIGNANT HYPERTHERMIAThe Lancet, 1983
- The Neuroleptic Malignant SyndromeArchives of internal medicine (1960), 1982
- Neuroleptic Malignant syndrome caused by dopamine‐depleting drugs in a patient with Huntington diseaseNeurology, 1981
- Neuroleptic Malignant Syndrome-like State Following a Withdrawal of Antiparkinsonian DrugsJournal of Nervous & Mental Disease, 1981
- Neuroleptic Malignant SyndromeArchives of Neurology, 1980